6505--Semaglutide (Ozempic) Inj Soln - GLP1A Glucagon-like Peptide 1 Receptor Agonists
Award Notice Posted
- Solicitation number
- 36E79720R0055
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Awarded
- to Novo Nordisk Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36E79720D0071 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center awarded contract 36E79720D0071 to NOVO NORDISK INC. on September 22, 2020 for $598,189,800 to supply Semaglutide injection solution, which is a glucagon-like peptide 1 receptor agonist used to treat diabetes. The solicitation number for this opportunity to provide this diabetes treatment was 36E79720R0055.
Notice text
Awarded contract 36E79720D0071 to NOVO NORDISK INC. for 598189800.00000000 on 2020-09-22.
Files
| File | Type | Posted |
|---|---|---|
| 36E79720D0071_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| 6505--GLP1A Glucagon-like Peptide 1 Receptor Agonists | Solicitation | |
| 6505--GLP1A Glucagon-like Peptide 1 Receptor Agonists | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity